Select Language

  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About
Navigation Menu
  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About

Disease or Vaccine: Pneumonia

Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated With Conjugate Pneumococcal Vaccines

March 30, 2021

By Brooke Farrenkopf

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

February 10, 2021

By Brooke Farrenkopf

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

February 10, 2021

By Brooke Farrenkopf

Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland

September 3, 2020

By Brooke Farrenkopf

Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic epidemiological analysis using data from India

September 17, 2019

By Kirthini Muralidharan

Maternal influenza immunization and prevention of severe clinical pneumonia in young infants

June 4, 2019

By Kirthini Muralidharan

Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: a case-cohort study

June 4, 2019

By Kirthini Muralidharan

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

May 22, 2019

By Kirthini Muralidharan

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States

May 21, 2019

By Kirthini Muralidharan

Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination

May 21, 2019

By Kirthini Muralidharan

Posts navigation

Older posts

Web Policies      Translation Disclaimer

VoICE is a project of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Johns Hopkins Bloomberg School of Public Health
www.jhsph.edu/ivac

Please email the VoICE editor with any questions or comments.

  • Contact Us
  • twitter

Stay Connected

© 2023, The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Learn more from the Johns Hopkins University Privacy Statement.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT